Skip to main content
Arunjyoti Bio Ventures Limited logo

Arunjyoti Bio Ventures Limited — Investor Relations & Filings

Ticker · 530881 ISIN · INE485K01022 LEI · 984500863WAB14C05151 BSE.NS Manufacturing
Open in API
Filings indexed 3 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 530881

About Arunjyoti Bio Ventures Limited

https://www.abvl.co.in/

Arunjyoti Bio Ventures Limited focuses on the manufacturing and distribution of a comprehensive range of beverages. The company’s primary product portfolio encompasses fruit juices, carbonated soft drinks, and packaged drinking water. It operates specialized production facilities designed to meet rigorous quality and safety standards in beverage processing. By integrating modern technology with efficient supply chain management, the firm delivers a variety of consumer-centric liquid refreshments. Its operations are centered on scaling production capabilities and expanding market reach through a diverse distribution network, catering to the evolving preferences of the retail consumer market.

Recent filings

Filing Released Lang Actions
Newspaper Publication for the Audited Financial Results for the Quarter and year ended 31.03.2026
Interim / Quarterly Report Classification · 78% confidence The document is a letter to the stock exchange enclosing copies of audited financial results published in newspapers for the quarter and year ended March 31, 2026, and then reproduces the full tabular extracts of those audited quarterly (and year‐end) results. It contains actual financial statement numbers and substantive data (income, profit, EPS, ratios) rather than merely a high‐level summary or notice that a report is available. Under our taxonomy, this corresponds to an Interim/Quarterly Report (IR) rather than a brief earnings release (ER) or mere publication notice (RPA). FY 2016
2026-05-14 English
Audited Financial Statements for the Quarter and Year ended 31.03.2026
Audit Report / Information Classification · 87% confidence The document is a SEBI/BSE listing disclosure titled “Outcome of Board Meeting” dated May 13, 2026, in which the Board has approved and attached the audited financial results and Auditor’s Report for the quarter and year ended 31 March 2026. The text then includes full audited financial statements (Statement of Assets & Liabilities, Profit & Loss, Cash Flows) and detailed notes prepared under Ind AS along with the auditor’s sign-off. This is not a brief earnings highlight (ER), not merely a board change notice (MANG), not a proxy or dividend notice, nor an annual narrative report (10-K). Rather, it is a standalone audited financial report with the auditor’s opinion—which falls squarely under “Audit Report / Information” (AR).
2026-05-13 English
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Regulatory Filings Classification · 82% confidence The document is a notice to the stock exchange (BSE Limited) regarding the postponement and rescheduling of a board meeting date. It contains no financial data, no report publication, no change in board composition, and no dividend or share issue information. It is a routine regulatory compliance announcement falling into the general “Regulatory Filings” category.
2026-05-12 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.